Ozdi Almasi Balogh Pal Korhaz
- Address
- Beke Utca 1-3, 3600 Ozd, Hungary
Ozdi Almasi Balogh Pal Korhaz - Critical Care & Hematology Research Center
Ozdi Almasi Balogh Pal Korhaz is a clinical research facility specializing in acute care and emergency medicine interventions. The center demonstrates particular expertise in managing life-threatening conditions requiring urgent therapeutic interventions, with a focus on severe infectious diseases and anticoagulation management in hospitalized patients.
- Severe community-acquired pneumonia (sCAP) treatment and immunomodulation research
- Reversal of direct oral Factor Xa inhibitor-induced anticoagulation
- Emergency surgical and invasive procedure management in anticoagulated patients
The research center conducts Phase 3 clinical trials evaluating advanced therapeutic approaches for critically ill patients. Their work encompasses investigations of trimodulin for severe respiratory infections and novel anticoagulation reversal agents such as TAK-330 for patients on direct oral anticoagulants requiring urgent procedures. The facility's research portfolio reflects its commitment to addressing time-sensitive clinical scenarios where rapid intervention is essential for patient survival and optimal outcomes.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 332 other sites in Hungary
Therapeutic Area Benchmark — Hungary
Select a therapeutic area to compare against other sites in Hungary.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Hungary
Market Share
Country: Hungary
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Ozdi Almasi Balogh Pal Korhaz
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Phase 3 Evaluation of TAK-330 for Reversal of Direct Oral Factor Xa Inhibitor Anticoagulation in Patients Requiring Urgent Surgical Intervention | Takeda Development Center Americas Inc. | Phase III | Recruiting | Jul 2022 | — |
IMP list
lock Showing 1 of 7 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Human Coagulation Factor Ii | 1 | Unknown | 2022-07-20 | 2022-07-20 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.